-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation